Equine VLP-1 antibody and antigen (recombinant protein)

Diagnostic anti-Equine VLP-1 antibodies pairs and antigen for animal health (animal Equine/Horse Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-VLP-1-Ag01Equine VLP-1$3090.00
GMP-EQU-VLP-1-Ab01Anti-Equine VLP-1 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-VLP-1-Ab02Anti-Equine VLP-1 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-VLP-1-Ab03Anti-Equine VLP-1 human monoclonal antibody (mAb)$3090.00
GMP-EQU-VLP-1-Ab04Anti-Equine VLP-1 human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-VLP-1-Ag01
Product NameEquine VLP-1
Target/BiomarkerEquine VLP-1
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine VLP-1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in VLP-1 level test of animal Equine/Horse with Alzheimer Disease(AD).
TagHis
Reconized/Reactive SpecicsEquine VLP-1
Product descriptionRecombinant Equine VLP-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-VLP-1-Ab01,GMP-EQU-VLP-1-Ab02
Target/BiomarkerEquine VLP-1
Product NameAnti-Equine VLP-1 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine VLP-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VLP-1 antibodies in Equine VLP-1 level test of animal Equine/Horse with Alzheimer Disease(AD).
Product descriptionAnti-Equine VLP-1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VLP-1 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-VLP-1-Ab03,GMP-EQU-VLP-1-Ab04
Target/BiomarkerEquine VLP-1
Product NameAnti-Equine VLP-1 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine VLP-1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine VLP-1 antibodies in Equine VLP-1 level test of animal Equine/Horse with Alzheimer Disease(AD).
Product descriptionAnti-Equine VLP-1 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine Vaccinia-Like Particles-1 (VLP-1) assumes a captivating role within the intricate tapestry of equine immunology. At its core, VLP-1 is a remarkable molecular structure, resembling viral particles, yet devoid of the genetic material necessary for viral replication. Structurally, it primarily consists of protein subunits that encapsulate fragments of equine DNA.

    VLP-1's significance transcends its structural resemblance to viruses. Instead, it plays a pivotal role in the equine immune response, particularly in the context of viral infections and vaccinations. When horses encounter viral pathogens or receive vaccines, their immune system orchestrates a coordinated defense. Part of this intricate defense involves the synthesis and release of VLP-1 by immune cells. This biomarker serves as a molecular beacon, signaling the activation of the immune system, particularly in response to viral antigens.

    Notably, VLP-1 is not a disease-causing entity; rather, it functions as an amplifier of the equine immune response. Its virus-like appearance acts as a catalyst, fostering a robust immunological reaction. This process primes the equine immune system, preparing it to recognize and combat actual viral threats with heightened efficiency. It is a cornerstone of the equine immune defense against viral adversaries.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.